CHARACTERIZATION OF NK CELLS IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA11This work was supported in part by NIH grant CA-29910; by ACS grant IM-387; by a fellowship grant(to Y.F.) from the Norris Cancer Center; and by a Leukemia Society of America Scholar Award(to P.K.P).
- 1 January 1985
- book chapter
- Published by Elsevier
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2Science, 1984
- Differentiation stages of human natural killer cells in lymphoid tissues from fetal to adult life.The Journal of Experimental Medicine, 1983
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982
- Lysis of fresh human B-lymphocyte-derived leukemia cells by interferon-activated natural killer (NK) cellsInternational Journal of Cancer, 1982
- Lysis of human B-lymphocyte-derived lymphoma/leukemia cells of established cell lines by interferon-activated natural killer (NK) cellsInternational Journal of Cancer, 1981
- Chronic Myelogenous Leukemia — New ConceptsNew England Journal of Medicine, 1981
- Chronic Myelogenous Leukemia — New ConceptsNew England Journal of Medicine, 1981
- Studies on Cytotoxicity Generated in Human Mixed Lymphocyte CulturesThe Journal of Immunology, 1979
- Activation of Human Natural Killer Cells Cytotoxic for Human Leukemia Cells by Purified InterferonThe Journal of Immunology, 1979
- Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosomeBlood, 1975